Although it has been demonstrated that the rescue therapy with GP IIb/IIIa inhibitors is associated with better outcomes in both ruptured and unruptured aneurysms, they are not easily reversed, resulting in increased hemorrhagic risk, especially in our case, where the patient was already prepared with the dual antiplatelet therapy for the procedure [6]. This evidence concerns the gene ITGA2B and aneurysm.